The abstract is read at the publisher; the summary is JClub's.
Variation in epitope-level T cell specificity across individuals remains largely untested as a critical factor shaping quantitative immune phenotypes in complex human infections and tumors.
- Why it matters: Current epitope-aware correlates of protection or risk are rarely established, because most human T cell profiling uses representative epitopes or bulk assays rather than epitope-resolved quantification at scale.
- What they did: The review argues that TCR repertoire profiling and reverse epitope discovery now enable formal tests of whether distinct epitope-level responses explain variability in human anti-pathogen and antitumor immunity.
- The result: It outlines approaches to measure how epitope variation contributes to the noise and variation seen in human immune phenotypes, supporting development of epitope-aware correlates.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.